<DOC>
	<DOCNO>NCT02091739</DOCNO>
	<brief_summary>The objective study investigate efficacy safety two different dose level NT 201 ( 75 U 100 U per cycle ) , compare placebo , reduce salivary flow rate , severity frequency chronic troublesome sialorrhea occur result various neurological condition adult subject .</brief_summary>
	<brief_title>Clinical Study Investigate Efficacy Safety Two Dose Levels NT 201 Versus Placebo Treating Chronic Troublesome Sialorrhea Various Neurological Conditions</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Sialorrhea</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Documented diagnosis basic neurological condition associate sialorrhea ( , ( ) , ( ii ) ( iii ) ; onset least 6 month screen ) . Chronic troublesome sialorrhea relate parkinsonism stroke traumatic brain injury ( least 3 month ) screening , define presence follow , screen baseline least 3 month screen ( retrospective response questionnaire impossible , statement equivalent severity suffice ) : 1 . A Drooling Severity Frequency Scale [ DSFS ] sum score least 6 point 2 . A score least 2 point item DSFS 3 . A score least 3 point modify Radboud Oral Motor Inventory Parkinson 's Disease [ mROMP ] , Section 'III Drooling ' , Item A ) . A score 2 point mROMP Section 'II Swallowing Symptoms ' Item A ) score 3 point Item C ) , screen baseline . Nonneurological secondary cause sialorrhea . Unstable concomitant medication influence sialorrhea ( anticholinergics treatment parkinsonism ; dosage medication must stable least 4 week study entry , i.e . screening , must plan remain stable course study . Recent ( i.e. , four week ) drug treatment sialorrhea . History recurrent aspiration pneumonia . Extremely poor dental/oral condition assess qualified dentist . Recent ( i.e. , one year sialorrhea , 14 week indication ) treatment know hypersensitivity Botulinum toxin , know hypersensitivity ingredient study preparation . Recent ( i.e. , four week ) change antiparkinsonian medication . Previous plan surgery irradiation control sialorrhea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>